A detailed history of General Partner, Inc. transactions in Amgen Inc stock. As of the latest transaction made, General Partner, Inc. holds 126 shares of AMGN stock, worth $37,110. This represents 0.03% of its overall portfolio holdings.

Number of Shares
126
Previous 126 -0.0%
Holding current value
$37,110
Previous $39.4 Million 3.12%
% of portfolio
0.03%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 07, 2023

BUY
$225.79 - $275.2 $28,449 - $34,675
126 New
126 $31.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track General Partner, Inc. Portfolio

Follow General Partner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Partner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on General Partner, Inc. with notifications on news.